ANITA/ ENGOT-Ov41/ GEICO 69-O
Trial Description:
A phase III randomized, double-blinded trial of platinum-based chemotherapy with or without atezolizumab followed by niraparib maintenance with or without atezolizumab in patients with recurrent ovarian, tubal or peritoneal cancer and platinum treatment-free interval (TFIp) >6 months
Lead Cooperative Group:
Trial Number:
Disease Site:
Ovarian
Trial Status:
Closed to Recruitment
Contact person:
agonzalez